Symptoms of acute transfusion reactions at a general referral hospital in Kinshasa, Democratic Republic of Congo: a cross-sectional study

Objectives Blood transfusion is a life-saving procedure and is also associated with a range of risks including the occurrence of symptoms of acute transfusion reactions (ATRs). Very few studies in sub-Saharan Africa have reported on ATRs. The present study addresses this gap in the literature by documenting the prevalence of and factors associated with ATRs in the Democratic Republic of Congo (DRC). Design This is a cross-sectional descriptive and analytical study using blood bank data from a general referral hospital. Setting Centre Hospitalier Mere-Enfant (CHME) Monkole, a general referral hospital in Kinshasa, DRC. Participants General population who have received blood transfusion in CHME Monkole between 2014 and 2019. Results The data set included a total of 7166 patients; 3153 (44%) men and 4013 (56%) women. The overall prevalence of symptoms of ATRs was 2.6%; the lowest prevalence was in 2017 (2.34%) and highest in 2018 (2.95%) and 2019 (2.94%). The documented symptoms included 74 (39.6%) cases of dyspnoea/respiratory distress, 60 (32.1%) cases of fever, 36 (19.2%) cases of pruritus/urticaria and 17 (9.1%) cases of vomiting. None of the studied factors was associated with symptoms of ATRs. Conclusion Symptoms of ATRs were not uncommon in the studied population. Dyspnoea and respiratory distress, fever and pruritus/urticaria were the most common symptoms of ATRs. This study highlights the need for a clinical and biological surveillance to detect, prevent and manage ATRs in the context of the DRC.

Automated summary

Blood transfusion is a life-saving procedure with associated risks, including acute transfusion reactions (ATRs). This study in the DRC documented a 2.6% prevalence of ATRs in blood transfusion recipients, with common symptoms being dyspnea, fever, and rash/hives. The study emphasizes the need for surveillance to detect, prevent, and manage ATRs in this context.